X0306 4 2020-12-08 0001472091 PDS Biotechnology Corp PDSB 0001770756 BEDU-ADDO FRANK C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD FLORHAM PARK NJ 07932 true true President/CEO Stock Option (Right to Buy) 2.43 2020-12-08 4 A 0 707800 0 A 2030-12-08 Common Stock 707800 707800 D The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation. /s/ Hillary Yegen, attorney-in-fact 2020-12-09